New Proposals for Testing Drugs with IKr-Blocking Activity to Determine Their Teratogenic Potential

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|29|2979-2988

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.29, 2007-10, pp. : 2979-2988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 962-967

Bentham Science Publishers

Access to resources Recommend Favorite

Teratogenic Potential of Atypical Antipsychotic Drugs, Quetiapine and Aripiprazole in Rats

By  

Current Psychopharmacology, Vol. 4, Iss. 2, 2016-02 ,pp. : 119-124

Bentham Science Publishers

Access to resources Recommend Favorite

Teratogenic Activity of HDAC Inhibitors

By  

Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-10 ,pp. : 5438-5442

Bentham Science Publishers

Access to resources Recommend Favorite

Teratogenic Potential of the Newer Antiepileptic Drugs: What is Known and How Should This Influence Prescribing?

By Palmieri C.   Canger R.  

CNS Drugs, Vol. 16, Iss. 11, 2002-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite

TERATOGENIC POTENTIAL OF ATRAZINE AND 2,4-D USING FETAX

By Morgan Marsha K.   Scheuerman Phillip R.   Bishop Creg S.   Pyles Rebecca A.  

Journal of Toxicology and Environmental Health, Vol. 48, Iss. 2, 1996-05 ,pp. : 151-168

Taylor & Francis Ltd

Access to resources Recommend Favorite